In this episode, ACD/Labs Vice President of Innovation and Informatics Strategy, Andrew Anderson, and Strategic Partnerships Director, Graham McGibbon continue their discussion on digitalization and digital transformation in the context of pharmaceutical R&D. They assess how well the industry is adapting to the current digital landscape, and what can be done to contribute to the overall digitalization process.Andrew and Graham also share their thoughts on how digitalization can be used al...
All content for The Analytical Wavelength is the property of ACD/Labs and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
In this episode, ACD/Labs Vice President of Innovation and Informatics Strategy, Andrew Anderson, and Strategic Partnerships Director, Graham McGibbon continue their discussion on digitalization and digital transformation in the context of pharmaceutical R&D. They assess how well the industry is adapting to the current digital landscape, and what can be done to contribute to the overall digitalization process.Andrew and Graham also share their thoughts on how digitalization can be used al...
Taking Charge of Drug Discovery: Understanding the Impact of Ionization in R&D
The Analytical Wavelength
19 minutes
1 year ago
Taking Charge of Drug Discovery: Understanding the Impact of Ionization in R&D
In this episode, ACD/Labs Senior Director of Technical and Scientific Services, Karim Kassam joins hosts Jesse and Bally to dive deeper into the importance of ionization. He gives us some insight into the tools available to help accurately predict pKa along with some hints and tips to help improve accuracy in predictions. Read more about the importance of ionization in pharmaceutical R&D in this blog post: The Importance of Ionization in Pharmaceutical R&D - ACD/Labs (acdlabs.co...
The Analytical Wavelength
In this episode, ACD/Labs Vice President of Innovation and Informatics Strategy, Andrew Anderson, and Strategic Partnerships Director, Graham McGibbon continue their discussion on digitalization and digital transformation in the context of pharmaceutical R&D. They assess how well the industry is adapting to the current digital landscape, and what can be done to contribute to the overall digitalization process.Andrew and Graham also share their thoughts on how digitalization can be used al...
